International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for …

F Bachelerie, A Ben-Baruch, AM Burkhardt… - Pharmacological …, 2014 - ASPET
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …

Maraviroc: a review of its use in HIV infection and beyond

SM Woollard, GD Kanmogne - Drug design, development and …, 2015 - Taylor & Francis
The human immunodeficiency virus-1 (HIV-1) enters target cells by binding its envelope
glycoprotein gp120 to the CD4 receptor and/or coreceptors such as CC chemokine receptor …

[PDF][PDF] Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study

V Ratziu, A Sanyal, SA Harrison, VWS Wong… - …, 2020 - Wiley Online Library
Background and Aims Cenicriviroc (CVC) is a C‐C chemokine receptors type 2 and 5 dual
antagonist under evaluation for treating liver fibrosis in adults with nonalcoholic …

A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek… - Hepatology, 2018 - journals.lww.com
Emerging studies have suggested that the Hippo pathway is involved in the tumorigenesis of
hepatocellular carcinoma (HCC). However, the key regulator of the Hippo pathway in liver …

Macrophages provide a transient muscle stem cell niche via NAMPT secretion

D Ratnayake, PD Nguyen, FJ Rossello, VC Wimmer… - Nature, 2021 - nature.com
Skeletal muscle regenerates through the activation of resident stem cells. Termed satellite
cells, these normally quiescent cells are induced to proliferate by wound-derived signals …

Antifibrotic effects of the dual CCR2/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis

E Lefebvre, G Moyle, R Reshef, LP Richman… - PloS one, 2016 - journals.plos.org
Background & Aims Interactions between CC chemokine receptor types 2 (CCR2) and 5
(CCR5) and their ligands, including CCL2 and CCL5, mediate fibrogenesis by promoting …

Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury

JC Mossanen, O Krenkel, C Ergen, O Govaere… - Hepatology, 2016 - journals.lww.com
Acetaminophen (APAP, paracetamol) poisoning is a leading cause of acute liver failure
(ALF) in humans and induces hepatocyte necrosis, followed by activation of the innate …

[PDF][PDF] Pharmacological inhibition of CCR2/5 signaling prevents and reverses alcohol‐induced liver damage, steatosis, and inflammation in mice

A Ambade, P Lowe, K Kodys, D Catalano… - …, 2019 - Wiley Online Library
Kupffer cell and macrophage (MØ) activation contributes to steatosis, inflammation, and
fibrosis in alcoholic liver disease (ALD). We found increased frequency of MØ, T cells, and …

Current progress in antiviral strategies

Z Lou, Y Sun, Z Rao - Trends in pharmacological sciences, 2014 - cell.com
The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus
(HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new …

[HTML][HTML] International Union of Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical …

F Bachelerie, A Ben-Baruch, AM Burkhardt… - Pharmacological …, 2014 - ncbi.nlm.nih.gov
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology
approved a system for naming human seven-transmembrane (7TM) G protein-coupled …